Pignatello Rosario, Ferro Marinella, Puglisi Giovanni
Dipartimento di Scienze Farmaceutiche, Universita di Catania, viale A. Doria, 6-I-95125 Catania, Italy.
AAPS PharmSciTech. 2002;3(2):E10. doi: 10.1208/pt030210.
This work studied the mechanisms of interaction between Eudragit RS100 (RS) and RL100 (RL) polymers with 3 nonsteroidal anti-inflammatory drugs: diflunisal (DIF), flurbiprofen (FLU), and piroxicam (PIR). Solid dispersions of polymers and drugs at different weight ratios were prepared by coevaporation of their ethanol solutions. The resulting coevaporates were characterized in the solid state (Fourier-transformed infrared spectroscopy (FT-IR) IR, differential scanning calorimetry, powder-x-ray diffractometry) as well as by studying the in vitro drug release in a gastroenteric environment. Absorption tests from drug solutions to the solid polymers were also performed to better explain the mechanism of interactions between them. The preparative conditions did not induce changes in the crystalline state of the drugs (amorphization or polymorphic change). Drugs strongly interacted with the ammonium groups present in polymers, giving an electrostatic interaction that reinforced the mere physical dispersion of drug molecules within polymer networks. Such interactions are related to the chemical structure of the drugs and to their dissociated or undissociated state. The dispersion of drugs in the polymer matrices strongly influenced their dissolution rate, which appeared slower and more gradual than those of the pure drugs, when polymer ratios were increased. RL coevaporates usually displayed higher dissolution rates. The kinetic evaluation of the dissolution profile, however, suggested that both the drug solubility in the external medium and its diffusion capacity within the polymer network are involved. In the sorption experiments, RL showed a greater adsorptive capacity than RS, in relation to the greater number of quaternary ammonium functions, which behave as activity sites for the electrostatic interactions. In the presence of Tris-HCl buffer (pH 7.4), drug adsorption was reduced, as a consequence of the competition of the chloride ions with drug anions for the polymer binding sites. In general, DIF and FLU displayed a similar interaction with RS and RL active sites; PIR's was different. The different molecular structures of these agents can justify such findings. The presence of a carboxyl group (instead of another dissociable acidic moiety, like the hydroxy-enolic one in the PIR molecule) could help explain the strong interaction with RS and RL polymers' quaternary ammonium centers. Preliminary studies like ours are important in helping develop better forecasting and increasing the understanding of the incorporation/release behavior of drugs from particulate delivery systems that can be made from these polymers.
本研究探讨了丙烯酸树脂RS100(RS)和RL100(RL)聚合物与3种非甾体抗炎药:二氟尼柳(DIF)、氟比洛芬(FLU)和吡罗昔康(PIR)之间的相互作用机制。通过共蒸发聚合物和药物的乙醇溶液,制备了不同重量比的聚合物-药物固体分散体。采用傅里叶变换红外光谱(FT-IR)、差示扫描量热法和粉末X射线衍射法对所得共蒸发物进行了固态表征,并研究了其在胃肠环境中的体外药物释放情况。还进行了药物溶液对固体聚合物的吸附试验,以更好地解释它们之间的相互作用机制。制备条件未引起药物晶态的变化(非晶化或多晶型转变)。药物与聚合物中存在的铵基团强烈相互作用,产生静电相互作用,增强了药物分子在聚合物网络中的物理分散。这种相互作用与药物的化学结构及其解离或未解离状态有关。当聚合物比例增加时,药物在聚合物基质中的分散强烈影响其溶解速率,其溶解速率比纯药物慢且更平缓。RL共蒸发物通常表现出较高的溶解速率。然而,溶解曲线的动力学评估表明,药物在外部介质中的溶解度及其在聚合物网络中的扩散能力均起作用。在吸附实验中,由于季铵官能团数量较多,RL表现出比RS更大的吸附能力,这些官能团作为静电相互作用的活性位点。在Tris-HCl缓冲液(pH 7.4)存在下,由于氯离子与药物阴离子竞争聚合物结合位点,药物吸附减少。一般来说,DIF和FLU与RS和RL活性位点表现出相似的相互作用;PIR则不同。这些药物不同的分子结构可以解释这些发现。羧基的存在(而不是另一个可解离的酸性部分,如PIR分子中的羟基烯醇式)有助于解释与RS和RL聚合物季铵中心的强烈相互作用。像我们这样的初步研究对于帮助更好地预测和加深对药物从由这些聚合物制成的微粒给药系统中的包封/释放行为的理解非常重要。